Application of human umbilical cord blood-derived mesenchymal stem cells in disease models

doi:10.4252/wjsc.v2.i2.34

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5602)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

403

HTML

5065

Figures (1-1)

134

Sum=5602

Apr 26, 2010 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Apr 26, 2010; 2(2): 34-38
Published online Apr 26, 2010. doi: 10.4252/wjsc.v2.i2.34

Open in New Tab Full Size Figure Download Figure

Figure 1 Multifunctional therapeutic activities of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs). Transplanted hUCB-MSCs participate in cartilage, lung and liver regeneration through differentiation of damaged tissues as well as attenuation of inflammation and apoptosis. Interestingly, hUCB-MSCs can migrate toward glioma. When migrated hUCB-MSCs express apoptotic gene such as TRAIL in glioma region, tumor size will be decreased by secreted TRAIL from hUCB-MSCs.

Citation: Kim JY, Jeon HB, Yang YS, Oh W, Chang JW. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J Stem Cells 2010; 2(2): 34-38
URL: https://www.wjgnet.com/1948-0210/full/v2/i2/34.htm
DOI: https://dx.doi.org/10.4252/wjsc.v2.i2.34